Connecticut Considers Pharma Bill SB 270

Connecticut is considering SB 270, a bill that seeks to limit physician-pharmaceutical industry interaction.

Connecticut joins New York, Minnesota, and many other states by considering SB 270, a bill that seeks to limit physician-pharmaceutical industry interaction. During a debate in late February in a Public Health Committee hearing for the Connecticut General Assembly, the

Register to view the full article

Register for MeetingsNet.com and gain access to premium content including the CMI 25 Listing, our monthly digital edition, the MeetingsNet app, live and on-demand webinars, and much more.

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish